norcantharidin has been researched along with Cancer of Prostate in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YS; Chiou, HL; Hsieh, YH; Hui, SC; Lee, CH; Lin, CY; Wu, MH | 1 |
Chen, CM; Cheng, CW; Hsieh, YH; Lee, CH; Lin, CL | 1 |
Gao, J; Hu, Z; Li, H; Li, J; Mo, L; Shi, X; Wei, L; Zhang, X; Zheng, D | 1 |
He, PJ; Shao, CL; Shen, B | 1 |
Chou, CY; Hu, DN; Kao, YH; Lin, IC; Wu, YC; Yang, PY | 1 |
5 other study(ies) available for norcantharidin and Cancer of Prostate
Article | Year |
---|---|
Norcantharidin combined with paclitaxel induces endoplasmic reticulum stress mediated apoptotic effect in prostate cancer cells by targeting SIRT7 expression.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Endoplasmic Reticulum Stress; Humans; Male; Paclitaxel; Prostatic Neoplasms; Sirtuins | 2021 |
Norcantharidin induces mitochondrial-dependent apoptosis through Mcl-1 inhibition in human prostate cancer cells.
Topics: Animals; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Forkhead Transcription Factors; Humans; Male; Mice; MicroRNAs; Mitochondria; Myeloid Cell Leukemia Sequence 1 Protein; Oncogene Protein v-akt; Prostatic Neoplasms; Transcription Factors; Xenograft Model Antitumor Assays | 2017 |
Norcantharidin enhances antitumor immunity of GM-CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Cancer Vaccines; Cell Proliferation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphocytes, Tumor-Infiltrating; Male; Mice; Prostatic Neoplasms; T-Lymphocytes, Regulatory | 2018 |
Norcantharidin induced DU145 cell apoptosis through ROS-mediated mitochondrial dysfunction and energy depletion.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Bisbenzimidazole; Blotting, Western; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Dose-Response Relationship, Drug; Flow Cytometry; Humans; In Situ Nick-End Labeling; Male; Membrane Potential, Mitochondrial; Micronucleus Tests; Mitochondria; Proliferating Cell Nuclear Antigen; Prostatic Neoplasms; Reactive Oxygen Species; Superoxide Dismutase | 2013 |
Norcantharidin induces apoptosis in human prostate cancer cells through both intrinsic and extrinsic pathways.
Topics: Apoptosis; bcl-2-Associated X Protein; Bridged Bicyclo Compounds, Heterocyclic; Caspases; Cell Line, Tumor; Cytochromes c; fas Receptor; Humans; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; TNF Receptor-Associated Death Domain Protein; Up-Regulation | 2016 |